Research
Research Library
Referenced articles on retatrutide and incretin science — clinical trial results, drug comparisons, mechanisms and safety data.
Comparison of Ozempic and Retatrutide
August 20, 2026 · 4 min read
Ozempic (semaglutide) vs retatrutide: mechanism of action, weight-loss efficacy (15% vs 26–30%), pros and cons, side-effect profiles and clinical outlook.
Comparison of Tirzepatide and Retatrutide
August 24, 2026 · 6 min read
Tirzepatide vs retatrutide compared: dual vs triple agonist mechanisms, weight-loss data (22.5% vs 30.3%), liver fat reduction, side effects and availability.
The “Triple-G” Miracle: Tracking Retatrutide's Record-Breaking TRIUMPH Trials
August 20, 2026 · 6 min read
Tracking retatrutide's record-breaking TRIUMPH trials: 28-30% weight loss, results by trial (TRIUMPH-1 to 4), dose vs dropout data, side effects and approval timeline.
Battle of the Sexes: How Men and Women Respond Differently to Retatrutide
August 21, 2026 · 5 min read
How men and women respond differently to retatrutide: women lose a higher percentage (25.3% vs 22.8%), men lose more absolute pounds, plus sex-specific side effects.
Taming the “Triple-G”: How to Minimize Side Effects on Retatrutide
August 22, 2026 · 5 min read
How to minimize retatrutide side effects: dose titration data, nausea and constipation remedies, heart rate tips, and side-effect rates by maintenance dose.
A Complete Casual Guide to Retatrutide: Reconstitution, Dosing, and Math Made Easy
August 23, 2026 · 6 min read
How to mix retatrutide with bacteriostatic water: step-by-step reconstitution, the peptide math formula, and a complete dosage chart with syringe units for 10mg-84mg vials.
What is “GLP-3”? The Next-Gen Weight Loss Nickname Explained
August 24, 2026 · 5 min read
GLP-3 is the internet's nickname for triple-agonist drugs like retatrutide, which target GLP-1, GIP and glucagon at once. What it means, how it compares, and when it arrives.